Zydus Lifesciences Ltd. (including its subsidiaries and affiliates), a global innovation-driven healthcare company, announced that it has entered into an exclusive licensing and commercialization agreement with RK Pharma Inc of the US for a novel sterile injectable 505(b)(2) oncology supportive care product for the US…
Exyte, a global leader in the design, engineering, and delivery of high-tech facilities, has completed the integration of Pharmaplan, marking the full transition of the Pharmaplan brand to Exyte and unifying biopharma engineering capabilities under one organization. In September 2024, Exyte announced the acquisition o…
Veeva Systems announced that Roche Pharmaceuticals has chosen to extend its partnership with Veeva Systems by adopting Veeva Vault CRM. "Roche and Veeva have partnered for many years," said Veeva CEO Peter Gassner. "We are honored to extend our partnership to Vault CRM and bring the next generation of AI-enabled CRM …
GenEditBio Limited ("GenEditBio"), a Hong Kong-headquartered clinical-stage biotechnology company specializing in novel deliveries, including lipid nanoparticle (LNP)-based delivery systems, announced that it has entered into a strategic cross-license agreement with ToolGen Inc., a leading genome editing company based…
Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics for immunology and oncology, announced an update and advancement of its global strategic collaboration with AstraZeneca, originally established in March 2025. The collaboration aims to discover …
AAVantgarde closing a Series B financing round, AGC Biologics announced a new manufacturing agreement with the biotechnology company, marking AGC Biologics’ latest advancement in the adeno-associated virus market. Under this agreement, AGC Biologics will provide Good Manufacturing Practice manufacturing for AAVantgard…
Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I announced a non-exclusive license agreement with Pfizer designed to accelerate preclinical antibody discovery across a range of potential disease indications. Under the terms of th…
Ginkgo Bioworks announced its partnership with the Institute for Genomic Biology at the University of Illinois Urbana-Champaign on a five-year initiative funded by the Advanced Research Projects Agency for Health (ARPA-H). The collaboration, Microbe/phage Investigation for Generalized Health TherapY (MIGHTY), aims to …
Freenome, an early cancer detection company developing blood-based screening tests, announced a strategic collaboration agreement with Roche to commercialize Freenome's cancer screening technology in international markets. In addition, Freenome will evaluate Roche's forthcoming Sequencing by Expansion (SBX) technology…
Zymo Research, a global leader in next-generation sequencing (NGS), has entered a strategic partnership with biomodal, an omics-based life sciences technology and analytics company. As part of biomodal's certified provider network, Zymo Research's NGS Services division is now authorized to deliver services using biomo…
Page 23 of 37